The British Pharmaceutical Conference & Exhibition 2007


Programme
PROGRAMME LINKS Monday - Tuesday - Wednesday	am Wednesday 12 September

10.00 – 10.30 COFFEE, TEA, EXHIBITION, BPC-PJ CAREERS FORUM AND POSTERS

The science of pharmacy	Science into practice	The practice of pharmacy

	9.00 – 9.30 Conference Science Medal 2006
10.30 – 12.30 A choice of:	In the chair: Professor Clive Wilson, Science Chair, BPC 2007	10.30 – 12.30 A choice of:
Reducing the risks of conterfeiting	Regenerating Organs - and Other Small Challenges Dr Molly Stevens, Imperial College London	From Manchester to Malta – communicating to patients across Europe
In association with the Academy of Pharmaceutical Sciences, the Industrial Pharmacists Group and Joint Pharmaceutical Analysis Group	9.30 – 10.00	In the chair: Shirley Norton, Medicines and Healthcare products Regulatory Agency
In the chair: Dr Carol Thomson, GlaxoSmithKline and Professor Tony Moffat, University of London	Chemist and Druggist Practice Research Award	Overview of EU initiatives
	In the chair: Professor Theo Raynor, Practice Chairman, BPC 2007	Shirley Norton, Medicines and Healthcare products Regulatory Agency
	The prescribing process in secondary care	Getting patients involved in medicines information policy
Counterfeiting of Medicines: an industry perspective	Dr Mary Tully, University of Manchester	Dr Isabelle Moulon, European Agency for the Evaluation of Medicinal Products
Sandra Lindon, GlaxoSmithKline		Experience of patient groups Alison Bowser, Acne Support Group
Analytical techniques for identification of counterfeit medicines	10.30 – 12.30 Ensuring the safety of herbal medicines: pharmacovigilance and interactions with drugs	Web-based medicines information can companies communicate?
Dr Andrew O’Neil, University of London		Jeremy Mean, State Institute for Drug Control, Prague
Product authentication and use in the pharmacy setting	In the chair: Professor Liz Williamson, Reading University	The role of the pharmacist
Rob Whewell, Aegate	Pharmacovigilance of herbal medicines: where we are now	Colette McCreedy, National Pharmacy Association
The regulatory challenges of counterfeit medicines	Dr Dick Middleton, MH Pharma Ltd
Dr Ged Lee, Medicines and Healthcare products Regulatory Agency	Safety also depends on quality: examples from TCM	Or
	Professor Kelvin Chan, Wolverhampton University	Ask about medicines: what about the children?
Or	Herb-drug interactions: the extent of the problem	Sponsored by
From genomics to medicine	Professor Liz Williamson, Reading University	Sponsored by
In the chair: Dr Sanober Shaikh, Royal Pharmaceutical Society of Great Britain and Institute of Psychiatry, King’s College London (Honorary)	Drug interactions with Echinacea: does it matter how the product is made? Professor Michael Heinrich, University of London	In the chair: V’Iain Fenton May, Cardiff and Vale NHS Trust

		Scene setting
Pharmacogenomic opportunities in drug development		Joanne Shaw, Ask About Medicines
Dr Nicholas Dracopoli, Bristol-Myers Squibb, USA		Information for licensed and unlicensed medicines
Pharmacogenetics: a SNPshot into the future of personalised prescribing		Steve Tomlin, Guy’s and St Thomas’ Hospital NHS Trust
Dr Monsheel Sodhi, Vanderbilt University Medical Centre, USA		Information for adolescents: is the internet the answer?
Applications of pharmacogenomics to mental health: research and future prospects		Dr Nicola Gray, University of Nottingham
Dr Kathy Aitchison, Institute of Psychiatry, King’s College London		Or
Pharmacogenetics of drug-induced blistering skin reactions		Patients, practitioners and prescribing: perceptions and processes
Dr Clive Bowman, GlaxoSmithKline Research Statistics Unit		Selected papers in pharmacy practice research
		In the chair: Professor Marjorie Weiss, University of Bath and Professor John Cromarty, Highland Acute Hospitals NHS Trust
Or
Challenges in drug delivery
In the chair: Dr Luigi G. Martini, GlaxoSmithKline and Dr Martin Grosvenor, AstraZeneca

Drug delivery and big pharma
Dr David Wyatt, GlaxoSmithKline
New approaches to formulate hydrophobic drugs
Professor Steve Brocchini, University of London
The problem with alcohol
Dr Matt Roberts, Liverpool John Moores University
Drug delivery from polymeric scaffolds for tissue engineering
Professor Kevin Shakessheff, University of Nottingham

Or
Cutting-edge drug design
In the chair: Professor Barry Potter, University of Bath

Steroid sufatase inhibitors: from concept to clinic
Professor Barry Potter, University of Bath
A pharmacological map of the PI3-kinase family
Dr Zachary Knight, University of California, USA
Discovery and preclinical development of kinase inhibitors as targeted agents for oncology indications
Dr Louis J Lombardo, Bristol-Myers Squibb
Fragment based drug discovery: from crystal to clinic
Dr Brian Williams, Astex Therapeutics Ltd


12.30 – 13.45 LUNCH, EXHIBITION BPC-PJ CAREERS FORUM AND POSTERS
	pm Wednesday 12 September

The science of pharmacy	Science into practice	The practice of pharmacy


13.45 – 14.00 Introduction of BPC 2008 Science Chair		13.45 – 14.00 Introduction of BPC 2008 Practice Chair
Professor Andrew Lloyd, University of Brighton		Professor Carmel Hughes, Queen’s University Belfast
Announcement of the 2007 Conference Science Award
		14.00 – 14.30 Keynote address Errors and risk: what is the link?
14.00 – 14.30		In the chair: Professor Theo Raynor, Practice Chairman, BPC 2007
GlaxoSmithKline Industrial Achievement Award session		Professor Nick Barber, University of London
In the chair: Professor Clive Wilson, Science Chairman, BPC 2007

14.30 – 16.30 A choice of:	14.30 – 16.30 A choice of:	14.30 – 16.30 A choice of:
Myths, rumours and evidence	Prevention better than cure? Prevention versus treatment following the emerging pattern of blindness in the Western World	Pharmacists with a special interest(PhwSI)
In association with Sense About Science		In the chair: Beth Taylor, NHS Primary Care Contracting
In the chair: Ellen Raphael, Sense About Science	In the chair: Orest Olejnik, Allergan	What are PhwSIs? Beth Taylor, NHS Primary Care Contracting
	Looking ahead: a new era in AMD care.	The commissioners view of PhwSIs Dr Steve Henderson, NHS North West
The mysterious charm of homoeopathy	Baljean Dhillon, Princess Alexandra Eye Pavilion, Edinburgh	Substance misuse in community pharmacy Tim Cottingham, Community Pharmacist
Professor Raymond Tallis, University of Manchester	So how do we manage glaucoma?	Providing a primary care dermatology service
Time to stop monkeying around	Fiona Spencer, Manchester Royal Eye Hospital, Manchester	Dr. Rod Tucker,HMP Hull and Hull PCT
Kirk Leech, Research Defence Society	Retinal drug delivery: Issues and resolutions	Or
Cleansing the system, or just clearing out your wallet? The truth about detox	Dr Patrick Hughes, Allergan, California, USA	Pharmacy in a secure environment In association with the Prison Pharmacists’ Forum
Dr Joanne Lunn, British Nutrition Foundation	New treatments, cost and choice in the 21st Century	In the chair: John Gentle, Deputy Chairman, BPC Conference Committee
	Michael Lavin, Manchester Royal Eye Hospital, Manchester	General introduction to the prison environment and medicines within it
Or		Dr Cliff Howells, Prison Health Integrated Drug Treatment
Science short talks in pharmacognosy and pharmaceutical chemistry For further information, click here	Or	Strategy, Department of Health Prison health and the IDTS - an overview
In the chair: Dr John Spencer, Greenwich University	Listen and learn about risks and benefits: what the patient needs to know and how to tell them	Carol Lange, East Midlands Pharmacy Services and Christine Rowlands, Her Majesty’s Prison, Leeds
	Undergraduate students and preregistration session	Medicines – to have and to hold
Or	Undergraduate students and preregistration session	Cathy Cooke, Prison Pharmacists’ Forum
Short talks in drug delivery For further information, click here	In the chair: Julie Sowter, University of Leeds and Professor Carmel Hughes, Queen’s University Belfast	Prison Pharmacists’ Forum - Mrs Devan Eustace
In the chair: Dr Barbara Conway, Aston University and Dr Christine Dufés, University of Strathclyde		Or
	Communicating risks and benefits to patients: what needs to be done	The appropriate use of medicines: the role of information
Or	Sonya Mash, St Bartholomew’s Hospital, London.	Selected papers in pharmacy practice research
Genotoxic impurities	What do students need to be taught?	In the chair: Dr Imogen Savage, London School of Pharmacy and Dr Paul Bissell, University of Nottingham
In the chair: Dr Dave Elder, GlaxoSmithKline	Dr Peter Knapp, University of Leeds
	How M.Pharm prepared me for managing risk as a pharmacist
The EU position	Jennifer de val, British Pharmaceutical Students’ Association
Dr Leon van Aerts, RIVM, The Netherlands	How to teach about risks and benefits Speaker to be announced
General overview
Dr Dave Elder, GlaxoSmithKline
Industry perspective on the Guideline and its impact
Dr Andrew Teasdale, AstraZeneca
Genotoxic impurities in Excipients: regulatory implications
Dr Carl Mroz, IPEC Europe Regulatory Affairs

16.30 CONFERENCE CONCLUDES

Top of Page ↑

PROGRAMME LINKS Monday - Tuesday - Wednesday
home - theme - highlights - programme - social events - call for papers - booking - press releases - awards